VANDA PHARMACEUTICALS INC. Accrued Liabilities and Other Liabilities
VANDA PHARMACEUTICALS INC. (VNDA) had Accrued Liabilities and Other Liabilities of $43.56 million as of 2015-06-30, per its 10-Q filed 2015-07-31.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2015-07-31
- 2015-06-30: Accrued Liabilities and Other Liabilities $43.56M.
- 2015-03-31: Accrued Liabilities and Other Liabilities $30.30M.
- 2014-12-31: Accrued Liabilities and Other Liabilities $6.95M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2015-06-30 | $43.56M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $30.30M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $6.95M 10-Q · filed 2015-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |